BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 27149193)

  • 1. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
    Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
    J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
    Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors.
    Reshma RS; Jeankumar VU; Kapoor N; Saxena S; Bobesh KA; Vachaspathy AR; Kolattukudy PE; Sriram D
    Bioorg Med Chem; 2017 May; 25(10):2761-2771. PubMed ID: 28389113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikimate kinase, a protein target for drug design.
    Coracini JD; de Azevedo WF
    Curr Med Chem; 2014; 21(5):592-604. PubMed ID: 24164195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium tuberculosis shikimate kinase inhibitors: design and simulation studies of the catalytic turnover.
    Blanco B; Prado V; Lence E; Otero JM; Garcia-Doval C; van Raaij MJ; Llamas-Saiz AL; Lamb H; Hawkins AR; González-Bello C
    J Am Chem Soc; 2013 Aug; 135(33):12366-76. PubMed ID: 23889343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
    Simithy J; Reeve N; Hobrath JV; Reynolds RC; Calderón AI
    Tuberculosis (Edinb); 2014 Mar; 94(2):152-8. PubMed ID: 24429106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shikimate kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: kinetics and structural dynamics of a potential molecular target for drug development.
    Saidemberg DM; Passarelli AW; Rodrigues AV; Basso LA; Santos DS; Palma MS
    Curr Med Chem; 2011; 18(9):1299-310. PubMed ID: 21366533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multifaceted approach to identify non-specific enzyme inhibition: Application to Mycobacterium tuberculosis shikimate kinase.
    Alturki MS; Fuanta NR; Jarrard MA; Hobrath JV; Goodwin DC; Rants'o TA; Calderón AI
    Bioorg Med Chem Lett; 2018 Feb; 28(4):802-808. PubMed ID: 29366649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
    Kumar M; Verma S; Sharma S; Srinivasan A; Singh TP; Kaur P
    Chem Biol Drug Des; 2010 Sep; 76(3):277-84. PubMed ID: 20626408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new
    Mehra R; Chib R; Munagala G; Yempalla KR; Khan IA; Singh PP; Khan FG; Nargotra A
    Mol Divers; 2015 Nov; 19(4):1003-19. PubMed ID: 26232029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations.
    Vianna CP; de Azevedo WF
    J Mol Model; 2012 Feb; 18(2):755-64. PubMed ID: 21594693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S; Abdullah M; Sriram D; Guruprasad L
    J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase.
    Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY
    Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C-δ inhibitor, Rottlerin inhibits growth and survival of mycobacteria exclusively through Shikimate kinase.
    Pandey S; Chatterjee A; Jaiswal S; Kumar S; Ramachandran R; Srivastava KK
    Biochem Biophys Res Commun; 2016 Sep; 478(2):721-6. PubMed ID: 27498028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments.
    Freitas de Freitas T; Roth CD; Abbadi BL; Hopf FSM; Perelló MA; de Matos Czeczot A; de Souza EV; Borsoi AF; Machado P; Bizarro CV; Basso LA; Timmers LFSM
    J Comput Aided Mol Des; 2023 Mar; 37(3):117-128. PubMed ID: 36547753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2'-oxidase.
    Landge S; Mullick AB; Nagalapur K; Neres J; Subbulakshmi V; Murugan K; Ghosh A; Sadler C; Fellows MD; Humnabadkar V; Mahadevaswamy J; Vachaspati P; Sharma S; Kaur P; Mallya M; Rudrapatna S; Awasthy D; Sambandamurthy VK; Pojer F; Cole ST; Balganesh TS; Ugarkar BG; Balasubramanian V; Bandodkar BS; Panda M; Ramachandran V
    Bioorg Med Chem; 2015 Dec; 23(24):7694-710. PubMed ID: 26643218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the Catalytic Mechanism and the Nature of the Transition State of an Attractive Drug-Target Enzyme (Shikimate Kinase) by Quantum Mechanical/Molecular Mechanical (QM/MM) Studies.
    Yao J; Wang X; Luo H; Gu P
    Chemistry; 2017 Nov; 23(64):16380-16387. PubMed ID: 28925075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.